Answer
Inluriyo (imlunestrant) is contraindicated in patients with hypersensitivity to imlunestrant or any of the excipients listed in section 6.1 of the product information.
Sources for this answer
- Inluriyo 200 mg film-coated tabletsEli Lilly and Company Limited · emc · SmPC §4.3 Contraindications · Version 1Document updated
Sources checked